Psychometric properties of the Positive and Negative Affect Schedule (PANAS) in a heterogeneous sample of substance users

American Journal of Drug and Alcohol Abuse

Volumn 42, Issue 2, 2016, Pages 203-212

  Serafini, Kelly ^a   Malin Mayor, Bo ^b   Nich, Charla ^a   Hunkele, Karen ^a   Carroll, Kathleen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Affect; Cocaine; PANAS; Substance use

Indexed keywords

ABSTINENCE; ADDICTION SEVERITY INDEX; AFRICAN AMERICAN; BRIEF SYMPTOM INVENTORY; CONTROLLED CLINICAL TRIAL; DISCRIMINANT VALIDITY; ERROR; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; MALE; META ANALYSIS; MODEL; POSITIVE AND NEGATIVE AFFECT SCHEDULE; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TEST RETEST RELIABILITY; TREATMENT OUTCOME; AFFECT; BEHAVIOR ASSESSMENT; DRUG USE; FACTOR ANALYSIS; PSYCHOLOGY; PSYCHOMETRY; REPRODUCIBILITY;

AFFECT; BEHAVIOR RATING SCALE; DRUG USERS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84959051763     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2015.1133632     Document Type: Article

References (50)

1. de Graaf R, Radovanovic M, Van Laar M, Fairman B, Degenhardt L, Aguilar-Gaxiola S, Bruffaerts R, et al. Early cannabis use and estimated risk of later onset of depression spells: epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am J Epidemiol 2010;172:149-159.
2. Glantz MD, Anthony JC, Berglund PA, Degenhardt L, Dierker A, Kalaydjian A, Merikangas KR, et al. Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med 2009;39:1365-1377.
3. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiat 1997;54:313-321.
4. Baker TB, Japuntich SJ, Hogle JM, McCarthy DE, Curtin JJ. Pharmacologic and behavioral withdrawal from addictive drugs. Curr Dir Psychol Sci 2006;15:232-236.
5. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997;278:52-58.
6. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, Handlesman L. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992;11:184-190.
7. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine. Am J Psychiat 1985;142:1259-1264.
8. Stice E. A prospective test of the dual-pathway model of bulimic pathology: mediating effects of dieting and negative affect. J Abnorm Psychol 2001;110:124-135.
9. Vrieze E, Demyttenaere K, Bruffaerts R, Hermans D, Pizzagalli DA, Sienaert P, Hompes T, et al. Dimensions in major depressive disorder and their relevance for treatment outcome. J Affect Disorders 2014;155:35-41.
10. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988;54:1063-1070.
11. Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, et al. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend 2002;67:219-223.
12. Uva MCDS, Timary PD, Cortesi M, Mikolajczak M, Blicquy PDRD, Luminet O. Moderating effect of emotional intelligence on the role of negative affect in the motivation to drink in alcohol-dependent subjects undergoing protracted withdrawal. Pers Indiv Differ 2010;48:16-21.
13. Martens MP, Neighbors C, Lewis MA, Lee CM, Oster-Aaland L, Larimer ME. The roles of negative affect and coping motives in the relationship between alcohol use and alcohol-related problems among college students. J Stud Alcohol Drugs 2008;69:412-419.
14. Carpenter KM, Hasin DS. Drinking to cope with negative affect and DSM-IV alcohol use disorders: a test of three alternative explanations. J Stud Alcohol Drugs 1999;60:694-704.
15. Magura S, Rosenblum A, Lovejoy M, Handelsman L, Foote J, Stimmel B. Neurobehavioral treatment for cocaine-using methadone patients: a preliminary report. J Addict Dis 1995;13:143-160.
16. Handelsman L, Rosenblum A, Palij M, Magura S, Foote J, Lovejoy M, Stimmel B. Bromocriptine for cocaine dependence. Am J Addiction 1997;6:54-64.
17. Weiss NH, Williams DC, Connolly KM. Preliminary examination of negative affect, emotion dysregulation, and risky behaviors among military veterans in residential substance abuse treatment. Military Behavioral Health 2015;3:212-218.
18. Olson KL, Cooper RL, Nugent WR, Reid RC. Addressing negative affect in substance use relapse prevention. J Human Behav Soc Environ 2015 6; 26:2-14.
19. Crawford JR, Henry JD. The Positive and Negative Affect Schedule (PANAS): construct validity, measurement properties and normative data in a large nonclinical sample. Br J Clin Psychol 2004;43:245-265.
20. Mackinnon A, Jorm AF, Christensen H, Korten AE, Jacomb PA, Rodgers B. A short form of the Positive and Negative Affect Schedule: evaluation of factorial validity and invariance across demographic variables in a community sample. Pers Indiv Differ 1999;27:405-416.
21. Merz EL, Malcarne VL, Roesch SC, Ko CM, Emerson M, Roma VG, Sadler GR. Psychometric properties of Positive and Negative Affect Schedule (PANAS) original and short forms in an African American community sample. J Affect Disorders 2013;151:942-949.
22. Schmukle SC, Egloff B, Burns LR. The relationship between positive and negative affect in the Positive and Negative Affect Schedule. J Res Pers 2002;36:463-475.
23. Tuccitto DE, Giacobbi PR, Leite WL. The internal structure of positive and negative affect: a confirmatory factor analysis of the PANAS. Educ Psychol Meas 2009;1:1-17.
24. Diener E, Larsen RJ, Levine S, Emmons RA. Intensity and frequency: dimensions underlying Positive and Negative Affect. J Pers Soc Psychol 1985;48:1253-1265.
25. Gaudreau P, Sanchez X, Blondin JP. Positive and negative affective states in a performance-related setting: testing the factorial structure of the PANAS across two samples of French-Canadian participants. Eur J Psychol Assess 2006;22:240-249.
26. Killgore WDS. Evidence for a third factor on the Positive and Negative Affect Schedule in a college student sample. Percept Motor Skill 2000;90:147-152.
27. Leue A, Beauducel A. The PANAS structure revisited: on the validity of a bifactor model in community and forensic samples. Psychol Assessment 2011;23:215-225.
28. Mehrabian A. Comparison of the PAD and PANAS as models for describing emotions and for differentiating anxiety from depression. J Psychopathol Behav 1997;19:331-357.
29. Bradley B, DeFife JA, Guarnaccia C, Phifer J, Fani N, Ressler KJ, Westen D. Emotion dysregulation and negative affect: association with psychiatric symptoms. J Clin Psychiatry 2011;72:685-691.
30. Carroll KM, Ball SA, Martino S, Nich C, Gordon MA, Portnoy GA, Rounsaville BJ. Computer-assisted delivery of cognitive behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiat 2008;165:881-889.
31. Carroll KM, Nich C, LaPaglia DM, Peters EN, Easton CJ, Petry NM. Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: Less can be more, more or less. Addiction 2012;107:1650-1659.
32. Carroll KM, Kiluk BD, Nich C, Gordon MA, Portnoy GA, Marino DR, Ball SA. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiat 2014;171:436-444.
33. Carroll KM, Nich C, Petry NM, Eagan DA, Shi JM, Ball SA, Sofuoglu M. Disulfiram and contingency management to enhance CBT for cocaine dependence: effects on cocaine use and preliminary evidence for interactions with dopamine B-hydroxylase polymorphism. Drug Alcohol Depen. In press.
34. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition, January 1995 FINAL: SCID-I/P Version 2.0. New York, NY: Biometrics Research Department, New York State Psychiatric Institute.
35. Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med 1983;13:595-605.
36. Thomas ML. Rewards of bridging the divide between measurement and clinical theory: demonstration of a bifactor model for the Brief Symptom Inventory. Psychol Assessment 2012;24:101-113.
37. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992;9:199-213.
38. McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise, D. The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addiction 2006;15:113-124.
39. Bentler PM. Comparative fit indexes in structural models. Psychol Bull 1990;107:238-246.
40. Steiger JS. Structural model evaluation and modification: an interval estimation approach. Multivar Behav Res 1990;25:173-180.
41. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 1999;6:1-55.
42. Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long JS, editors. Testing structural equation models. Newbury Park, CA: Sage; 1993. pp 136-162.
43. Messick S. Validity of psychological assessment: validation of inferences from persons' responses and performances as scientific inquiry into score meaning. Am Psychol 1995;50:741-749.
44. Higgins ST, Wong CJ, Badger GJ, Ogden DEH, Dantona RL. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psych 2000;68:64-72.
45. Zevon MA, Tellegen A. The structure of mood change: an idiographic/nomothetic analysis. J Pers Soc Psychol 1982;43:111-122.
46. Thompson ER. Development and validation of an internationally reliable short-form of the positive and negative affect schedule (PANAS). J Cross Cult Psychol 2007;38:227-242.
47. Kambouropoulos N, Staiger PK. The influence of sensitivity to reward on reactivity to alcohol-related cues. Addiction 2001;96:1175-1185.
48. Carrico AW, Woods WJ, Siever MD, Discepola MV, Dilworth SE, Neilands TB, Miller N, Moskowitz JT. Positive affect and processes of recovery among treatment-seeking methamphetamine users. Drug Alcohol Depen 2013;132:624-629.
49. Hall SM, Havassy BE, Wasserman DA. Effects of commitment to abstinence, positive moods, stress, and coping on relapse to cocaine use. J Consult Clin Psych 1991;59:526-532.
50. McHugh RK, Kaufman JS, Frost KH, Fitzmaurice GM, Weiss RD. Positive affect and stress reactivity in alcohol-dependent outpatients. J Stud Alcohol Drugs 2013;74:152-157.